Montelukast 4 MG Chewable Tablet — RxCUI 311759
RxNorm drug concept · Semantic clinical drug
RxCUI 311759
Semantic clinical drug · SCD
● Current RxNorm concept 45 FDA products
124 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI311759
Official nameMontelukast 4 MG Chewable Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmontelukast 4 MG (as montelukast sodium 4.2 MG) Chewable Tablet; montelukast sodium 4 MG Chewable Tablet
FDA products mapped45
Package NDCs mapped124
Reported Medicaid activity (SDUD)3,576,073 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Montelukast: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It is used for long-term control of asthma, preventing breathing trouble triggered by exercise, and relieving seasonal and year-round allergy symptoms like a stuffy or runny nose....
- For asthma, take it once daily in the evening, with or without food. For exercise-triggered symptoms, take it at least 2 hours before exercise. If you have both asthma and allergie...
- No. Montelukast doesn't reverse an attack, so keep your rescue inhaler handy. You can keep taking montelukast during flare-ups, but use your rescue medicine when symptoms hit.
- Can I use it for a sudden asthma attack?
🕸️ Concept Web — How Montelukast 4 MG Chewable Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Montelukast 4 MG Chewable Tablet
RxCUI 311759 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Montelukast
88249IN
-
Montelukast
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Singulair
153889BN
-
Singulair
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Montelukast Chewable Tablet
374624SCDF -
Montelukast Chewable Product
1295640SCDG -
Montelukast Oral Product
1157311SCDG -
Montelukast Pill
1157312SCDG -
Montelukast Chewable Tablet [Singulair]
369654SBDF -
Singulair Chewable Product
1296363SBDG -
Singulair Oral Product
1183693SBDG -
Singulair Pill
1183694SBDG - +4 more in this family
-
Montelukast Chewable Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Montelukast 4 MG
330865SCDC -
Montelukast 4 MG Chewable Tablet [Singulair]
261367SBD -
Montelukast 4 MG [Singulair]
542404SBDC
-
Montelukast 4 MG
Showing up to 8 concepts per family — 13 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Montelukast 4 MG
SCDC · 330865 -
Montelukast Chewable Tablet
SCDF · 374624 -
Montelukast Chewable Product
SCDG · 1295640 -
Montelukast Oral Product
SCDG · 1157311 -
Montelukast Pill
SCDG · 1157312
Brand-Name Concepts
-
Montelukast 4 MG Chewable Tablet [Singulair]
SBD · 261367 -
Montelukast 4 MG [Singulair]
SBDC · 542404 -
Montelukast Chewable Tablet [Singulair]
SBDF · 369654 -
Singulair Chewable Product
SBDG · 1296363 -
Singulair Oral Product
SBDG · 1183693 -
Singulair Pill
SBDG · 1183694 -
Singulair
BN · 153889
📦 FDA Products & Package NDCs
45 products · 124 package NDCs
124 package NDCs map to RxCUI 311759 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 13668-0079-05 | 500 TABLET, CHEWABLE in 1 BOTTLE (13668-079-05) | Montelukast Sodium | Torrent Pharmaceuticals Limited | 2012-08-03 |
| 13668-0079-30 | 30 TABLET, CHEWABLE in 1 BOTTLE (13668-079-30) | Montelukast Sodium | Torrent Pharmaceuticals Limited | 2012-08-03 |
| 13668-0079-90 | 90 TABLET, CHEWABLE in 1 BOTTLE (13668-079-90) | Montelukast Sodium | Torrent Pharmaceuticals Limited | 2012-08-03 |
| 13668-0080-05 | 500 TABLET, CHEWABLE in 1 BOTTLE (13668-080-05) | Montelukast Sodium | Torrent Pharmaceuticals Limited | 2012-08-03 |
| 13668-0080-30 | 30 TABLET, CHEWABLE in 1 BOTTLE (13668-080-30) | Montelukast Sodium | Torrent Pharmaceuticals Limited | 2012-08-03 |
| 13668-0080-90 | 90 TABLET, CHEWABLE in 1 BOTTLE (13668-080-90) | Montelukast Sodium | Torrent Pharmaceuticals Limited | 2012-08-03 |
| 13668-0081-05 | 500 TABLET in 1 BOTTLE (13668-081-05) | Montelukast Sodium | Torrent Pharmaceuticals Limited | 2012-08-03 |
| 13668-0081-30 | 30 TABLET in 1 BOTTLE (13668-081-30) | Montelukast Sodium | Torrent Pharmaceuticals Limited | 2012-08-03 |
| 13668-0081-32 | 3200 TABLET in 1 BOTTLE (13668-081-32) | Montelukast Sodium | Torrent Pharmaceuticals Limited | 2012-08-03 |
| 13668-0081-74 | 100 TABLET in 1 CARTON (13668-081-74) | Montelukast Sodium | Torrent Pharmaceuticals Limited | 2012-08-03 |
| 13668-0081-90 | 90 TABLET in 1 BOTTLE (13668-081-90) | Montelukast Sodium | Torrent Pharmaceuticals Limited | 2012-08-03 |
| 13668-0531-94 | 30 PACKET in 1 CARTON (13668-531-94) / 500 mg in 1 PACKET (... | Montelukast Sodium | Torrent Pharmaceuticals Limited | 2017-03-30 |
| 27241-0015-31 | 30 GRANULE in 1 CARTON (27241-015-31) | MONTELUKAST SODIUM | Ajanta Pharma USA Inc. | 2015-08-13 |
| 27241-0016-03 | 30 TABLET, CHEWABLE in 1 BOTTLE (27241-016-03) | MONTELUKAST SODIUM | Ajanta Pharma USA Inc. | 2015-08-13 |
| 27241-0016-09 | 90 TABLET, CHEWABLE in 1 BOTTLE (27241-016-09) | MONTELUKAST SODIUM | Ajanta Pharma USA Inc. | 2015-08-13 |
| 27241-0017-03 | 30 TABLET, CHEWABLE in 1 BOTTLE (27241-017-03) | MONTELUKAST SODIUM | Ajanta Pharma USA Inc. | 2015-08-13 |
| 27241-0017-09 | 90 TABLET, CHEWABLE in 1 BOTTLE (27241-017-09) | MONTELUKAST SODIUM | Ajanta Pharma USA Inc. | 2015-08-13 |
| 27241-0018-03 | 30 TABLET, COATED in 1 BOTTLE (27241-018-03) | MONTELUKAST SODIUM | Ajanta Pharma USA Inc. | 2015-08-13 |
| 27241-0018-09 | 90 TABLET, COATED in 1 BOTTLE (27241-018-09) | MONTELUKAST SODIUM | Ajanta Pharma USA Inc. | 2015-08-13 |
| 27241-0018-90 | 1000 TABLET, COATED in 1 BOTTLE (27241-018-90) | MONTELUKAST SODIUM | Ajanta Pharma USA Inc. | 2015-08-13 |
| 29300-0220-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-220-01) | montelukast sodium | Unichem Pharmaceuticals (USA), Inc. | 2016-01-01 |
| 29300-0220-10 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-220-10) | montelukast sodium | Unichem Pharmaceuticals (USA), Inc. | 2016-01-01 |
| 29300-0220-13 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-220-13) | montelukast sodium | Unichem Pharmaceuticals (USA), Inc. | 2016-01-01 |
| 29300-0220-19 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-220-19) | montelukast sodium | Unichem Pharmaceuticals (USA), Inc. | 2016-01-01 |
| 29300-0221-10 | 1000 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (29300-221-10) | montelukast sodium | Unichem Pharmaceuticals (USA), Inc. | 2018-08-20 |
| 29300-0221-13 | 30 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (29300-221-13) | montelukast sodium | Unichem Pharmaceuticals (USA), Inc. | 2018-08-20 |
| 29300-0221-19 | 90 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (29300-221-19) | montelukast sodium | Unichem Pharmaceuticals (USA), Inc. | 2018-08-20 |
| 29300-0222-10 | 1000 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (29300-222-10) | montelukast sodium | Unichem Pharmaceuticals (USA), Inc. | 2018-08-20 |
| 29300-0222-13 | 30 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (29300-222-13) | montelukast sodium | Unichem Pharmaceuticals (USA), Inc. | 2018-08-20 |
| 29300-0222-19 | 90 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (29300-222-19) | montelukast sodium | Unichem Pharmaceuticals (USA), Inc. | 2018-08-20 |
| 31722-0727-01 | 100 TABLET, CHEWABLE in 1 BOTTLE (31722-727-01) | montelukast sodium | Camber Pharmaceuticals, Inc. | 2015-05-27 |
| 31722-0727-10 | 1000 TABLET, CHEWABLE in 1 BOTTLE (31722-727-10) | montelukast sodium | Camber Pharmaceuticals, Inc. | 2015-05-27 |
| 31722-0727-30 | 30 TABLET, CHEWABLE in 1 BOTTLE (31722-727-30) | montelukast sodium | Camber Pharmaceuticals, Inc. | 2015-05-27 |
| 31722-0727-31 | 10 TABLET, CHEWABLE in 1 BLISTER PACK (31722-727-31) | montelukast sodium | Camber Pharmaceuticals, Inc. | 2015-05-27 |
| 31722-0727-32 | 100 TABLET, CHEWABLE in 1 CARTON (31722-727-32) | montelukast sodium | Camber Pharmaceuticals, Inc. | 2015-05-27 |
| 31722-0727-90 | 90 TABLET, CHEWABLE in 1 BOTTLE (31722-727-90) | montelukast sodium | Camber Pharmaceuticals, Inc. | 2015-05-27 |
| 31722-0728-01 | 100 TABLET, CHEWABLE in 1 BOTTLE (31722-728-01) | montelukast sodium | Camber Pharmaceuticals, Inc. | 2015-05-27 |
| 31722-0728-10 | 1000 TABLET, CHEWABLE in 1 BOTTLE (31722-728-10) | montelukast sodium | Camber Pharmaceuticals, Inc. | 2015-05-27 |
| 31722-0728-30 | 30 TABLET, CHEWABLE in 1 BOTTLE (31722-728-30) | montelukast sodium | Camber Pharmaceuticals, Inc. | 2015-05-27 |
| 31722-0728-31 | 10 TABLET, CHEWABLE in 1 BLISTER PACK (31722-728-31) | montelukast sodium | Camber Pharmaceuticals, Inc. | 2015-05-27 |
| 31722-0728-32 | 100 TABLET, CHEWABLE in 1 CARTON (31722-728-32) | montelukast sodium | Camber Pharmaceuticals, Inc. | 2015-05-27 |
| 31722-0728-90 | 90 TABLET, CHEWABLE in 1 BOTTLE (31722-728-90) | montelukast sodium | Camber Pharmaceuticals, Inc. | 2015-05-27 |
| 33342-0110-07 | 30 TABLET, CHEWABLE in 1 BOTTLE (33342-110-07) | Montelukast sodium | Macleods Pharmaceuticals Limited | 2015-03-13 |
| 33342-0110-10 | 90 TABLET, CHEWABLE in 1 BOTTLE (33342-110-10) | Montelukast sodium | Macleods Pharmaceuticals Limited | 2015-03-13 |
| 33342-0110-12 | 100 TABLET, CHEWABLE in 1 BLISTER PACK (33342-110-12) | Montelukast sodium | Macleods Pharmaceuticals Limited | 2015-03-13 |
| 33342-0110-15 | 500 TABLET, CHEWABLE in 1 BOTTLE (33342-110-15) | Montelukast sodium | Macleods Pharmaceuticals Limited | 2015-03-13 |
| 33342-0110-39 | 90 TABLET, CHEWABLE in 1 BLISTER PACK (33342-110-39) | Montelukast sodium | Macleods Pharmaceuticals Limited | 2015-03-13 |
| 33342-0110-44 | 1000 TABLET, CHEWABLE in 1 BOTTLE (33342-110-44) | Montelukast sodium | Macleods Pharmaceuticals Limited | 2015-09-25 |
| 33342-0111-07 | 30 TABLET, CHEWABLE in 1 BOTTLE (33342-111-07) | Montelukast sodium | Macleods Pharmaceuticals Limited | 2015-03-13 |
| 33342-0111-10 | 90 TABLET, CHEWABLE in 1 BOTTLE (33342-111-10) | Montelukast sodium | Macleods Pharmaceuticals Limited | 2015-03-13 |
Observed labelers:
Dr.Reddy's Laboratories Limited (13) ·
Camber Pharmaceuticals, Inc. (12) ·
Macleods Pharmaceuticals Limited (12) ·
Torrent Pharmaceuticals Limited (12) ·
Aurobindo Pharma Limited (10) ·
Unichem Pharmaceuticals (USA), Inc. (10)
· +12 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.